|
1
|
Ducci F and Goldman D: The genetic basis
of addictive disorders. Psychiatr Clin North Am. 35:495–519.
2012.PubMed/NCBI View Article : Google Scholar
|
|
2
|
American Psychiatric Association:
Diagnostic and Statistical Manual of Mental Disorders. 5th edition.
American Psychiatric Association, Washington, DC, 2013.
|
|
3
|
World Health Organization: ICD-10:
International Statistical Classification of Diseases and Related
Health Problems: 10th revision, 2nd edition. World Health
Organization, 2004. Available from: https://apps.who.int/iris/handle/10665/42980.
|
|
4
|
Rumpf HJ, Achab S, Billieux J,
Bowden-Jones H, Carragher N, Demetrovics Z, Higuchi S, King DL,
Mann K, Potenza M, et al: Including gaming disorder in the ICD-11:
The need to do so from a clinical and public health perspective. J
Behav Addict. 7:556–561. 2018.PubMed/NCBI View Article : Google Scholar
|
|
5
|
International Statistical Classification
of Diseases and Related Health Problems (11th edition) ICD-11,
World Health Organization, 2020.
|
|
6
|
Trifu S, Mihailescu R, Stegarescu S and
Ion I: Evolutional Perspective Over Some Key-Aspects in Psychiatry.
Theoretical and Applied in Psychology (SICAP23): Psychology and
Ongoing Development. Editografica, Bologna, pp179, 2016.
|
|
7
|
Winger G, Woods JH, Galuska CM and
Wade-Galuska T: Behavioral perspectives on the neuroscience of drug
addiction. J Exp Anal Behav. 84:667–681. 2005.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Koob GF and Volkow ND: Neurobiology of
addiction: A neurocircuitry analysis. Lancet Psychiatry. 3:760–773.
2016.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Jacqueline MV: Genetics of Addiction:
Future Focus on Gene x environment interaction? J Stud Alcohol
Drugs. 77:684–687. 2016.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Bierut LJ, Madden PA, Breslau N, Johnson
EO, Hatsukami D, Pomerleau OF, Swan GE, Rutter J, Bertelsen S, Fox
L, et al: Novel genes identified in a high-density genome wide
association study for nicotine dependence. Hum Mol Genet. 16:24–35.
2007.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Dick DM, Viken R, Purcell S, Kaprio J,
Pulkkinen L and Rose RJ: Parental monitoring moderates the
importance of genetic and environmental influences on adolescent
smoking. J Abnorm Psychol. 116:213–218. 2007.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Hancock DB, Markunas CA, Bierut LJ and
Johnson EO: Human genetics of addiction: New insights and future
directions. Curr Psychiatry Rep. 20(8)2018.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Trifu S, Tudor A and Rădulescu I:
Aggressive behavior in psychiatric patients in relation to hormonal
imbalance (Review). Exp Ther Med. 20:3483–3487. 2020.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Gräff J and Mansuy IM: Epigenetic
dysregulation in cognitive disorders. Eur J Neurosci. 30:1–8.
2009.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Schmidt HD, McGinty JF, West AE and
Sadri-Vakili G: Epigenetics and psychostimulant addiction. Cold
Spring Harb Perspect Med. 3(a012047)2013.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Cadet JL, Brannock C, Jayanthi S and
Krasnova IN: Transcriptional and epigenetic substrates of
methamphetamine addiction and withdrawal: Evidence from a
long-access self-administration model in the rat. Mol Neurobiol.
51:696–717. 2015.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Cadet JL: Epigenetics of stress,
addiction, and resilience: Therapeutic implications. Mol Neurobiol.
53:545–560. 2016.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Covington HE III, Maze I, Sun H, Bomze HM,
DeMaio KD, Wu EY, Dietz DM, Lobo MK, Ghose S, Mouzon E, et al: A
role for repressive histone methylation in cocaine-induced
vulnerability to stress. Neuron. 71:656–670. 2011.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Walker CD: Maternal touch and feed as
critical regulators of behavioral and stress responses in the
offspring. Dev Psychobiol. 52:638–650. 2010.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Mychasiuk R, Harker A, Ilnytskyy S and
Gibb R: Paternal stress prior to conception alters DNA methylation
and behaviour of developing rat offspring. Neuroscience.
241:100–105. 2013.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Benton D and Young HA: A meta-analysis of
the relationship between brain dopamine receptors and obesity: A
matter of changes in behavior rather than food addiction? Int J
Obes (Lond). 40 (Suppl 1):S12–S21. 2016.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Standaert DG and Walsh RR: Pharmacology of
dopaminergic neurotransmission. In: Principles of Pharmacology: The
Pathophysiologic Basis of Drug Therapy. Tashjian AH, Armstrong EJ
and Golan DE (eds). Lippincott Williams & Wilkins, Philadelphia
pp186-206, 2011.
|
|
23
|
Mishra A, Singh S and Shukla S:
Physiological and functional basis of dopamine receptors and their
role in neurogenesis: Possible implication for Parkinson's disease.
J Exp Neurosci: May 31, 2018 (Epub ahead of print). doi:
10.1177/1179069518779829.
|
|
24
|
Gardner EL: Addiction and brain reward and
antireward pathways. Adv Psychosom Med. 30:22–60. 2011.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Zhornitsky S, Rizkallah É, Pampoulova T,
Chiasson JP, Stip E, Rompré PP and Potvin S: Antipsychotic agents
for the treatment of substance use disorders in patients with and
without comorbid psychosis. J Clin Psychopharmacol. 30:417–424.
2010.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Frazer A and Hensler JG: Serotonin
Involvement in Physiological Function and Behavior. In: Basic
Neurochemistry: Molecular, Cellular and Medical Aspects. Siegel GJ,
Agranoff BW and Albers RW (eds). 6th edition. Lippincott-Raven,
Philadelphia, 1999.
|
|
27
|
Palacios JM, Pazos A and Hoyer D: A short
history of the 5-HT2C receptor: From the choroid plexus to
depression, obesity and addiction treatment. Psychopharmacology
(Berl). 234:1395–1418. 2017.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Maria Alexandra Stanescu A, Totan A,
Mircescu D, Diaconescu S, Gabriel Bratu O, Fekete L, László Fekete
G, Boda D and Cristina Diaconu C: Assessment of suicidal behavior
in dermatology (Review). Exp Ther Med. 20:73–77. 2020.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Kirby LG, Zeeb FD and Winstanley CA:
Contributions of serotonin in addiction vulnerability.
Neuropharmacology. 61:421–432. 2011.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Vogeler T, McClain C and Evoy KE:
Combination bupropion SR and varenicline for smoking cessation: A
systematic review. Am J Drug Alcohol Abuse. 42:129–139.
2016.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Zagon IS and McLaughlin PJ: Endogenous
Opioids in the Etiology and Treatment of Multiple Sclerosis. In:
Multiple Sclerosis: Perspectives in Treatment and Pathogenesis.
Zagon IS and McLaughlin PJ (eds). Codon Publications, Brisbane, AU,
2017.
|
|
32
|
Herman JP, Figueiredo HF, Mueller NK,
Ostrander MM, Zhang R, Tauchi M, Choi DC, Furay AR, Evanson NK,
Nelson EB, et al: Neurochemical Systems Regulating the
Hypothalamo-Pituitary-Adrenocortical Axis. In: Handbook of
Neurochemistry and Molecular Neurobiology. Lajtha A and Blaustein
JD (eds). Springer, Boston, pp513-569, 2007.
|
|
33
|
Browning KN and Travagli RA: Central
nervous system control of gastrointestinal motility and secretion
and modulation of gastrointestinal functions. Compr Physiol.
4:1339–1368. 2014.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Gilpin NW and Koob GF: Neurobiology of
alcohol dependence: Focus on motivational mechanisms. Alcohol Res
Health. 31:185–195. 2008.PubMed/NCBI
|
|
35
|
Aboujaoude E and Salame WO: Naltrexone: A
Pan-Addiction treatment? CNS Drugs. 30:719–733. 2016.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Mark GP, Shabani S, Dobbs LK and Hansen
ST: Cholinergic modulation of mesolimbic dopamine function and
reward. Physiol Behav. 104:76–81. 2011.PubMed/NCBI View Article : Google Scholar
|
|
37
|
Sofuoglu M and Mooney M: Cholinergic
functioning in stimulant addiction: Implications for medications
development. CNS Drugs. 23:939–952. 2009.PubMed/NCBI View Article : Google Scholar
|
|
38
|
Williams MJ and Adinoff B: The role of
acetylcholine in cocaine addiction. Neuropsychopharmacology.
33:1779–1797. 2008.PubMed/NCBI View Article : Google Scholar
|
|
39
|
Enoch MA: The role of GABA(A) receptors in
the development of alcoholism. Pharmacol Biochem Behav. 90:95–104.
2008.PubMed/NCBI View Article : Google Scholar
|
|
40
|
Tyacke RJ, Lingford-Hughes A, Reed LJ and
Nutt DJ: GABAB receptors in addiction and its treatment. Adv
Pharmacol. 58:373–396. 2010.PubMed/NCBI View Article : Google Scholar
|
|
41
|
Minozzi S, Saulle R and Rösner S: Baclofen
for alcohol use disorder. Cochrane Database Syst Rev.
11(CD012557)2018.PubMed/NCBI View Article : Google Scholar
|
|
42
|
Volkow ND and Morales M: The Brain on
drugs: From reward to addiction. Cell. 162:712–725. 2015.PubMed/NCBI View Article : Google Scholar
|
|
43
|
Li CT, Yang KC and Lin WCL: Glutamatergic
dysfunction and glutamatergic compounds for major psychiatric
disorders: Evidence from clinical neuroimaging studies. Front
Psychiatry. 9(767)2019.PubMed/NCBI View Article : Google Scholar
|
|
44
|
Schultz W: Neuronal reward and decision
signals: From theories to data. Physiol Rev. 95:853–951.
2015.PubMed/NCBI View Article : Google Scholar
|
|
45
|
Cooper S, Robison AJ and Mazei-Robison MS:
Reward circuitry in addiction. Neurotherapeutics. 14:687–697.
2017.PubMed/NCBI View Article : Google Scholar
|
|
46
|
Stott SRW and Ang SL: The Generation of
midbrain dopaminergic neurons. In: Patterning and Cell Type
Specification in the Developing CNS and PNS. Rubenstein JLR and
Rakic P (eds). Academic Press, Cambridge, pp435-453, 2013.
|
|
47
|
Olds J and Milner P: Positive
reinforcement produced by electrical stimulation of the septal area
and other regions of rat brain. J Comp Physiol Psychol. 47:419–27.
1954.PubMed/NCBI View Article : Google Scholar
|
|
48
|
Goeders NE and Smith JE: Cortical
dopaminergic involvement in cocaine reinforcement. Science.
221:773–775. 1983.PubMed/NCBI View Article : Google Scholar
|
|
49
|
Edenberg H and Foroud T: Genetics and
alcoholism. Nat Rev Gastroenterol Hepatol. 10:487–494.
2013.PubMed/NCBI View Article : Google Scholar
|
|
50
|
Vetreno RP and Crews FT: Current
hypotheses on the mechanisms of alcoholism. Handb Clin Neurol.
125:477–497. 2014.PubMed/NCBI View Article : Google Scholar
|
|
51
|
Sullivan EV and Pfefferbaum A:
Neurocircuitry in alcoholism: A substrate of disruption and repair.
Psychopharmacology (Berl). 180:583–594. 2005.PubMed/NCBI View Article : Google Scholar
|
|
52
|
Sharp BM and Chen H: Neurogenetic
determinants and mechanisms of addiction to nicotine and smoked
tobacco. Eur J Neurosci. 50:2164–2179. 2019.PubMed/NCBI View Article : Google Scholar
|
|
53
|
Benowitz NL: Pharmacology of nicotine:
Addiction, smoking-induced disease and therapeutics. Annu Rev
Pharmacol Toxicol. 49:57–71. 2009.PubMed/NCBI View Article : Google Scholar
|
|
54
|
D'Souza MS and Markou A: Neuronal
mechanisms underlying development of nicotine dependence:
Implications for novel smoking-cessation treatments. Addict Sci
Clin Pract. 6:4–16. 2011.PubMed/NCBI
|
|
55
|
Durazzo TC, Meyerhoff DJ and Nixon SJ:
Chronic cigarette smoking: Implications for neurocognition and
brain neurobiology. Int J Environ Res Public Health. 7:3760–3791.
2010.PubMed/NCBI View Article : Google Scholar
|
|
56
|
Nichols DE: Psychedelics. Pharmacol Rev.
68:264–355. 2016.PubMed/NCBI View Article : Google Scholar
|
|
57
|
López-Giménez JF and González-Maeso J:
Hallucinogens and Serotonin 5-HT(2A) receptor-mediated signaling
pathways. Curr Top Behav Neurosci. 36:45–73. 2018.PubMed/NCBI View Article : Google Scholar
|
|
58
|
Weir E: Inhalant use and addiction in
Canada. CMAJ. 164(397)2001.PubMed/NCBI
|
|
59
|
Kumar S, Grover S, Kulhara P, Mattoo SK,
Basu D, Biswas P and Shah R: Inhalant abuse: A clinic-based study.
Indian J Psychiatry. 50:117–120. 2008.PubMed/NCBI View Article : Google Scholar
|
|
60
|
Bloomfield MAP, Hindocha C, Green SF, Wall
MB, Lees R, Petrilli K, Costello H, Ogunbiyi MO, Bossong MG and
Freeman TP: The neuropsychopharmacology of cannabis: A review of
human imaging studies. Pharmacol Ther. 195:132–161. 2019.PubMed/NCBI View Article : Google Scholar
|
|
61
|
Devinsky O, Patel AD, Cross JH, Villanueva
V, Wirrell EC, Privitera M, Greenwood SM, Roberts C, Checketts D,
VanLandingham KE, et al: Effect of cannabidiol on drop seizures in
the Lennox-Gastaut syndrome. N Engl J Med. 378:1888–1897.
2018.PubMed/NCBI View Article : Google Scholar
|
|
62
|
McGuire P, Robson P, Cubala WJ, Vasile D,
Morrison PD, Barron R, Taylor A and Wright S: Cannabidiol (CBD) as
an adjunctive therapy in schizophrenia: A multicenter randomized
controlled trial. Am J Psychiatry. 175:225–231. 2018.PubMed/NCBI View Article : Google Scholar
|
|
63
|
Wijayendran SB, O'Neill A and
Bhattacharyya S: The effects of cannabis use on salience
attribution: A systematic review. Acta Neuropsychiatr. 30:43–57.
2018.PubMed/NCBI View Article : Google Scholar
|
|
64
|
Colizzi M, McGuire P, Pertwee RG and
Bhattacharyya S: Effect of cannabis on glutamate signalling in the
brain: A systematic review of human and animal evidence. Neurosci
Biobehav Rev. 64:359–381. 2016.PubMed/NCBI View Article : Google Scholar
|
|
65
|
Hirvonen J, Goodwin RS, Li CT, Terry GE,
Zoghbi SS, Morse C, Pike VW, Volkow ND, Huestis MA and Innis RB:
Reversible and regionally selective downregulation of brain
cannabinoid CB1 receptors in chronic daily cannabis smokers. Mol
Psychiatry. 17:642–649. 2017.PubMed/NCBI View Article : Google Scholar
|
|
66
|
Renard J, Vitalis T, Rame M, Krebs MO,
Lenkei Z, Le Pen G and Jay TM: Chronic cannabinoid exposure during
adolescence leads to long-term structural and functional changes in
the prefrontal cortex. Eur Neuropsychopharmacol. 26:55–64.
2016.PubMed/NCBI View Article : Google Scholar
|
|
67
|
Saffroy R, Lafaye G, Desterke C,
Ortiz-Tudela E, Amirouche A, Innominato P, Pham P, Benyamina A and
Lemoine A: Several clock genes polymorphisms are meaningful risk
factors in the development and severity of cannabis addiction.
Chronobiol Int. 36:122–134. 2019.PubMed/NCBI View Article : Google Scholar
|
|
68
|
Gerra MC, Manfredini M, Cortese E,
Antonioni MC, Leonardi C, Magnelli F, Somaini L, Jayanthi S, Cadet
JL and Donnini C: Genetic and environmental risk factors for
cannabis use: Preliminary results for the role of parental care
perception. Subst Use Misuse. 54:670–680. 2019.PubMed/NCBI View Article : Google Scholar
|
|
69
|
Hodgson K, Coleman JR, Hagenaars SP,
Purves KL, Glanville K, Choi SW, O'Reilly P and Breen G: Major
Depressive Disorder Working Group of the Psychiatric Genomics
Consortium. Lewis CM: Cannabis use, depression and self-harm:
Phenotypic and genetic relationships. Addiction. 115:482–492.
2020.PubMed/NCBI View Article : Google Scholar
|
|
70
|
Montalvo-Ortiz JL, Zhou H, D'Andrea I,
Maroteaux L, Lori A, Smith A, Ressler KJ, Nuñez YZ, Farrer LA, Zhao
H, et al: Translational studies support a role for serotonin 2B
receptor (HTR2B) gene in aggression-related cannabis response. Mol
Psychiatry. 23:2277–2286. 2018.PubMed/NCBI View Article : Google Scholar
|
|
71
|
Pasman JA, Verweij KJ, Gerring Z, Stringer
S, Sanchez-Roige S, Treur JL, Abdellaoui A, Nivard MG, Baselmans
BM, Ong JS, et al: GWAS of lifetime cannabis use reveals new risk
loci, genetic overlap with psychiatric traits, and a causal
influence of schizophrenia. Nat Neurosci. 21:1161–1170.
2018.PubMed/NCBI View Article : Google Scholar
|
|
72
|
Petrovska J, Coynel D, Fastenrath M,
Milnik A, Auschra B, Egli T, Gschwind L, Hartmann F, Loos E,
Sifalakis K, et al: The NCAM1 gene set is linked to depressive
symptoms and their brain structural correlates in healthy
individuals. J Psychiatr Res. 91:116–123. 2017.PubMed/NCBI View Article : Google Scholar
|
|
73
|
Trifu S, Vladuți A and Trifu AI: Genetic
aspects in schizophrenia. Receptoral theories. Metabolic theories.
Rom J Morphol Embryol. 61:25–32. 2020.PubMed/NCBI View Article : Google Scholar
|
|
74
|
Spahn V, Fischer O, Endres-Becker J,
Schäfer M, Stein C and Zöllner C: Opioid withdrawal increases
transient receptor potential vanilloid 1 activity in a protein
kinase A-dependent manner. Pain. 154:598–608. 2013.PubMed/NCBI View Article : Google Scholar
|
|
75
|
Le Merrer J, Becker JA, Befort K and
Kieffer BL: Reward processing by the opioid system in the brain.
Physiol Rev. 89:1379–412. 2009.PubMed/NCBI View Article : Google Scholar
|
|
76
|
Schramm-Sapyta NL, Walker QD, Caster JM,
Levin ED and Kuhn CM: Are adolescents more vulnerable to drug
addiction than adults? Evidence from animal models.
Psychopharmacology (Berl). 206:1–21. 2009.PubMed/NCBI View Article : Google Scholar
|
|
77
|
Van'tVeer A, Yano JM, Carroll FI, Cohen BM
and Carlezon WA Jr: Corticotropin-releasing factor (CRF)-induced
disruption of attention in rats is blocked by the κ-opioid receptor
antagonist JDTic. Neuropsychopharmacology. 37:2809–2816.
2012.PubMed/NCBI View Article : Google Scholar
|
|
78
|
Wang S: Historical review: Opiate
addiction and opioid receptors. Cell Transplant. 28:233–238.
2019.PubMed/NCBI View Article : Google Scholar
|
|
79
|
Wang SC, Chen YC, Lee CH and Cheng CM:
Opioid addiction, genetic susceptibility and medical treatments: A
review. Int J Mol Sci. 20(4294)2019.PubMed/NCBI View Article : Google Scholar
|
|
80
|
Gelernter J, Kranzler HR, Sherva R,
Koesterer R, Almasy L, Zhao H and Farrer LA: Genome-wide
association study of opioid dependence: Multiple associations
mapped to calcium and potassium pathways. Biol Psychiatry.
76:66–74. 2014.PubMed/NCBI View Article : Google Scholar
|
|
81
|
Kreek MJ, Nielsen DA and LaForge KS: Genes
associated with addiction: Alcoholism, opiate, and cocaine
addiction. Neuromolecular Med. 5:85–108. 2004.PubMed/NCBI View Article : Google Scholar
|
|
82
|
Brett J and Murnion B: Management of
benzodiazepine misuse and dependence. Aust Prescr. 38:152–155.
2015.PubMed/NCBI View Article : Google Scholar
|
|
83
|
Blum K, Gold M, Modestino EJ, Baron D,
Boyett B, Siwicki D, Lott L, Podesta A, Roy AK, Hauser M, et al:
Would induction of dopamine homeostasis via coupling genetic
addiction risk score (GARS®) and pro-dopamine regulation
benefit benzodiazepine use disorder (BUD)? J Syst Integr Neurosci:
May 3, 2018 (Epub ahead of print). doi: 10.15761/JSIN.1000196.
|
|
84
|
Blum K, Modestino EJ, Lewis MG, Baron D,
Steinberg B, Thanos PK, Downs BW, Siwicki D, Lott L, Braverman E,
et al: Pro-dopamine regulator (KB220) a fifty year sojourn to
combat reward deficiency syndrome (RDS): Evidence based
bibliography (Annotated). CPQ Neurol Psychol: Dec 4, 2018 (Epub
ahead of print).
|
|
85
|
Konopka A, Mak M, Grzywacz A, Murawiec S
and Samochowiec J: Genetic and psychosocial factors for
benzodiazepine addiction. An analysis based on the results of the
authors' own research conducted in a group of benzodiazepines
addicted and non-addicted individuals. Postepy Hig Med Dosw
(Online). 71:205–213. 2017.PubMed/NCBI View Article : Google Scholar
|
|
86
|
Gossop M, Griffiths P, Powis B and Strang
J: Cocaine: Patterns of use, route of administration, and severity
of dependence. Br J Psychiatry. 164:660–664. 1994.PubMed/NCBI View Article : Google Scholar
|
|
87
|
Coe MA, Jufer Phipps RA, Cone EJ and Walsh
SL: Bioavailability and pharmacokinetics of oral cocaine in humans.
J Anal Toxicol. 42:285–292. 2018.PubMed/NCBI View Article : Google Scholar
|
|
88
|
Olivares EL, Kendler KS, Neale MC and
Gillespie NA: The genetic and environmental association between
parental monitoring and risk of cannabis, stimulants, and cocaine
initiation in a sample of male twins: Does parenting matter? Twin
Res Hum Genet. 19:297–305. 2016.PubMed/NCBI View Article : Google Scholar
|
|
89
|
Jensen KP: A review of genome-wide
association studies of stimulant and opioid use disorders. Mol
Neuropsychiatry. 2:37–45. 2016.PubMed/NCBI View Article : Google Scholar
|
|
90
|
Le Q, Yan B, Yu X, Li Y, Song H, Zhu H,
Hou W, Ma D, Wu F, Zhou Y and Ma L: Drug-seeking motivation level
in male rats determines offspring susceptibility or resistance to
cocaine-seeking behaviour. Nat Commun. 8(15527)2017.PubMed/NCBI View Article : Google Scholar
|
|
91
|
Sepanjnia K, Modabbernia A, Ashrafi M,
Modabbernia MJ and Akhondzadeh S: Pioglitazone adjunctive therapy
for moderate-to-severe major depressive disorder: Randomized
double-blind placebo-controlled trial. Neuropsychopharmacology.
37:2093–2100. 2012.PubMed/NCBI View Article : Google Scholar
|
|
92
|
Chen X, Xue L, Hou S, Jin Z, Zhang T,
Zheng F and Zhan CG: Long-acting cocaine hydrolase for addiction
therapy. Proc Natl Acad Sci USA. 113:422–427. 2016.PubMed/NCBI View Article : Google Scholar
|
|
93
|
Yu S, Zhu L, Shen Q, Bai X and Di X:
Recent advances in methamphetamine neurotoxicity mechanisms and its
molecular pathophysiology. Behav Neurol.
2015(103969)2015.PubMed/NCBI View Article : Google Scholar
|
|
94
|
LaVoie MJ, Card JP and Hastings TG:
Microglial activation precedes dopamine terminal pathology in
methamphetamine-induced neurotoxicity. Exp Neurol. 187:47–57.
2004.PubMed/NCBI View Article : Google Scholar
|
|
95
|
Cadet JL and Bisagno V: Glial-neuronal
ensembles: Partners in drug addiction-associated synaptic
plasticity. Front Pharmacol. 5(204)2014.PubMed/NCBI View Article : Google Scholar
|
|
96
|
Krasnova IN, Justinova Z and Cadet JL:
Methamphetamine addiction: Involvement of CREB and
neuroinflammatory signaling pathways. Psychopharmacology (Berl).
233:1945–1962. 2016.PubMed/NCBI View Article : Google Scholar
|
|
97
|
Olsen CM: Natural rewards,
neuroplasticity, and non-drug addictions. Neuropharmacology.
61:1109–1122. 2011.PubMed/NCBI View Article : Google Scholar
|
|
98
|
Lobo DS, Souza RP, Tong RP, Casey DM,
Hodgins DC, Smith GJ, Williams RJ, Schopflocher DP, Wood RT,
el-Guebaly N and Kennedy JL: Association of functional variants in
the dopamine D2-like receptors with risk for gambling behaviour in
healthy Caucasian subjects. Biol Psychol. 85:33–7. 2010.PubMed/NCBI View Article : Google Scholar
|
|
99
|
Yau YH and Potenza MN: Gambling disorder
and other behavioral addictions: Recognition and treatment. Harv
Rev Psychiatry. 23:134–146. 2015.PubMed/NCBI View Article : Google Scholar
|
|
100
|
Moragas L, Granero R, Stinchfield R,
Fernández-Aranda F, Fröberg F, Aymamí N, Gómez-Peña M, Fagundo AB,
Islam MA, Del Pino-Gutiérrez A, et al: Comparative analysis of
distinct phenotypes in gambling disorder based on gambling
preferences. BMC Psychiatry. 15(86)2015.PubMed/NCBI View Article : Google Scholar
|
|
101
|
Kessler RC, Hwang I, LaBrie R, Petukhova
M, Sampson NA, Winters KC and Shaffer HJ: DSM-IV pathological
gambling in the National comorbidity survey replication. Psychol
Med. 38:1351–60. 2008.PubMed/NCBI View Article : Google Scholar
|
|
102
|
Grant JE, Odlaug BL and Chamberlain SR:
Neural and psychological underpinnings of gambling disorder: A
review. Prog Neuropsychopharmacol Biol Psychiatry. 65:188–193.
2016.PubMed/NCBI View Article : Google Scholar
|
|
103
|
Wilson D, da Silva Lobo DS, Tavares H,
Gentil V and Vallada H: Family-based association analysis of
serotonin genes in pathological gambling disorder: Evidence of
vulnerability risk in the 5HT-2A receptor gene. J Mol Neurosci.
49:550–553. 2013.PubMed/NCBI View Article : Google Scholar
|
|
104
|
Weinstein AM: Computer and video game
addiction-a comparison between game users and non-game users. Am J
Drug Alcohol Abuse. 36:268–276. 2010.PubMed/NCBI View Article : Google Scholar
|
|
105
|
Trifu S: Neuroendocrine insights into
burnout syndrome. Acta Endocrinol (Buchar). 15:404–405.
2019.PubMed/NCBI View Article : Google Scholar
|
|
106
|
Ko CH, Liu GC, Hsiao S, Yen JY, Yang MJ,
Lin WC, Yen CF and Chen CS: Brain activities associated with gaming
urge of online gaming addiction. J Psychiatr Res. 43:739–747.
2009.PubMed/NCBI View Article : Google Scholar
|
|
107
|
Park J, Sung JY, Kim DK, Kong ID, Hughes
TL and Kim N: Genetic association of human Corticotropin-releasing
hormone receptor 1 (CRHR1) with Internet gaming addiction in Korean
male adolescents. BMC Psychiatry. 18(396)2018.PubMed/NCBI View Article : Google Scholar
|
|
108
|
Franchina V, Vanden Abeele M, Van Rooij
AJ, Lo Coco G and De Marez L: Fear of Missing out as a predictor of
problematic social media use and phubbing behavior among Flemish
adolescents. Int J Environ Res Public Health.
15(2319)2018.PubMed/NCBI View Article : Google Scholar
|
|
109
|
Trifu S and Gutt A: Interpretative
process-from utilization of predominant to psychotic
decompensation. Procedia Soc Behav Sci. 187:429–433. 2014.
|
|
110
|
Ostlund SB and Balleine BW: On habits and
addiction: An associative analysis of compulsive drug seeking. Drug
Discov Today Dis Models. 5:235–245. 2008.PubMed/NCBI View Article : Google Scholar
|
|
111
|
Powell BJ, McMillen JC, Proctor EK,
Carpenter CR, Griffey RT, Bunger AC, Glass JE and York JL: A
compilation of strategies for implementing clinical innovations in
health and mental health. Med Care Res Rev. 69:123–157.
2012.PubMed/NCBI View Article : Google Scholar
|
